A Monocenter Prospective Study to Evaluate the Efficacy of Peripherally Inserted Central Catheter to Tunnelled Central Catheter With Cuff in Home Parenteral Nutrition for Long-term Used. (PICCNUT)
A Monocenter Prospective Study to Evaluate the Efficacy of Peripherally Inserted Central Catheter to Tunnelled Central Catheter With Cuff in Home Parenteral Nutrition for Long-term Used: the PICCnut Study.
Home parenteral nutrition (HPN) is the reference treatment for anatomic or fonctionnal chronic intestinal failure. Nutritionnal catheter must follow two rules: low infection rate and be able to preserve the permeability of the central vein. Today, in europeen guidelines, two types of central devices are recommended: tunnelled central catheter with cuff and implanted ports. However, their insertion is not without risk. Since many years, we have seen a new generation of catheter - peripherally inserted central catheter (PICC line)- which have many advantage over other central catheter. ESPEN guidelines accept the use of PICC line in short and moderate-term for HPN, but no prospective study have look for long-term used in HPN.
The objective of our study is to evaluate in a prospective randomised monocenter study the no-inferiority of PICC line to tunnelled central catheter with cuff for serious catheter related-complications such as infection and thrombophlebitis for patient on HPN over 1 month of duration. The secondary objectives are to: evaluate the number of patients with at least one serious complications related in 1000 days of used, the rate of minors and majors complications, number of catheter inserted, the satisfaction of patients and doctors.
The study is held in CHU Nice and will be proposed to hospitalized patients who will need HPN. After consent, patients will be randomized to receive PICC Line (group A) of nutritional central catheter with cuff (group B). Echography of vessels will be held at the beginning, 3 months and 12 months. Follow-up will be conduct at regular interval (month 0-1-3-6-9-12). The duration of follow-up will be of 12 months and the global duration of the study will be 36 months. One major complication will conduct to withdrawal of the study. There will be 55 patients in each group.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, Francia, 06200
- CHU de Nice
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- > 18 years-old
- Patients managed by CHU Nice for home parenteral nutrition
- Expected to have over 1 month of parenteral nutrition
- Signed consent
- Affiliation to Securite Social
Exclusion criteria
- Patient with nutritional catheter before inclusion
- Pregnancy or breastfeeding
- Evolutive pathology with life expectancy < 12 months
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Group B
After consent, patients will be randomised to PICC Line (group A) or tunnelled nutritional central catheter with cuff (group B).
Duration of inclusion will be 24 months.
After randomisation, patients will have catheter inserted by a competent radiologist following an echography.
Radiologist will have to answer a questionnaire and doctors will note any catheter-related complications.
|
After consent, patients will be randomised to PICC Line (group A) or tunnelled nutritional central catheter with cuff (group B).
Duration of inclusion will be 24 months.
After randomisation, patients will have catheter inserted by a competent radiologist following an echography.
Radiologist will have to answer a questionnaire and doctors will note any catheter-related complications.
After that, vessels echography will be systematically repeated at 3 months and 12 months for thrombosis research.
Follow-up visit will be held at 1,3,6,9 and 12 months.
At every step, major and minor complications will be noted by the investigators.
|
|
Experimental: Group A
PICC Line (group A) : patients will have catheter inserted by a competent radiologist following an echography.
Radiologist will have to answer a questionnaire and doctors will note any catheter-related complications.
|
Vessels echography will be systematically repeated at 3 months and 12 months for thrombosis research.
Follow-up visit will be held at 1,3,6,9 and 12 months.
At every step, major and minor complications will be noted by the investigators.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
major complications
Periodo de tiempo: 12 months
|
Statically significative difference between rate of incidence of major complications (infection and/or thrombosis related to catheter) during the 12 months follow-up.
|
12 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Delay
Periodo de tiempo: 12 months
|
Delay in days between insertion and first major complications
|
12 months
|
|
Questionnaire
Periodo de tiempo: 12 months
|
Questionnaire to evaluate catheter insertion by radiologist (satisfaction and complications). Satisfaction questionnaire to patients at every visit |
12 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: HEBUTERNE Xavier, PhD, CHU de Nice, Hôpital Archet, Pôle Digestif, 151 route de saint-antoine de ginestière 06200 Nice
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- 12-PP-02
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Insuficiencia intestinal crónica
-
Inje UniversityDesconocidoPacientes que evalúan la preparación intestinal mediante el uso de la aplicación SMARTPHONE (BPBUSA)PREPARACIÓN INTESTINAL (LIMPIEZA INTESTINAL)Corea, república de
-
Hospital Parc Taulí, SabadellTerminadoCáncer intestinal | Colonoscopia | Limpieza intestinalEspaña
-
Kosin University Gospel HospitalCell Biotech Co., Ltd.TerminadoColonoscopia | Preparación intestinal | Microbiota intestinalCorea, república de
-
University of ReadingDaniscoTerminadoMicrobiota intestinal | Función inmune | Función intestinal | Lípidos plasmáticosReino Unido
-
Gastroenterology Services, Ltd.TerminadoColonoscopia | Limpieza intestinal | Escala de calificación intestinalEstados Unidos
-
University of NottinghamNorthern Care Alliance NHS Foundation Trust; Cambridge University Hospitals NHS... y otros colaboradoresReclutamientoPseudoobstrucción intestinal crónicaReino Unido
-
Universidad de AlmeriaAún no reclutandoMicrobiota intestinal | Fuerza | Salud intestinal | Inflamación intestinal | Sistema digestivoEspaña
-
USDA, Western Human Nutrition Research CenterReclutamientoMicrobioma intestinal | Salud intestinal | Ingesta de yogur | Función inmune gastrointestinalEstados Unidos
-
Alfasigma S.p.A.Activo, no reclutandoPseudoobstrucción intestinal crónicaBélgica, Italia, España
-
Jinling Hospital, ChinaTerminadoEficacia y seguridad del trasplante de microbiota fecal para la pseudoobstrucción intestinal crónicaPseudoobstrucción intestinal crónicaPorcelana